Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.

Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol BTMD
- Company biote Corp.
- Price $3.17
- Changes Percentage 3.25
- Change 0.0998
- Day Low $3.17
- Day High $3.19
- Year High $8.44
- Year Low $3.04
- Market Cap $173,335,457
- Price Avg 50 EMA (D) $5.05
- Price Avg 200 EMA (D) $6.01
- Exchange NASDAQ
- Volume 12,183
- Average Volume 164,145
- Open $3.19
- Previous Close $3.07
- EPS 0.09
- PE 35.44
- Earnings Announcement 2025-05-05 10:59:00
- Shares Outstanding $54,337,134
Company brief: BIOTE CORP. (BTMD )
- Healthcare
- Medical - Care Facilities
- Ms. Teresa S. Weber
- https://biote.com
- US
- N/A
- 04-28-2021
- US0906831039
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
BTMD Corporation News
biote Corp. (BTMD) Q4 2024 Earnings Call Transcript
seekingalpha.com -- biote Corp. (NASDAQ:BTMD ) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Corporate Participants Szymon Serowiecki - Investor Relations Mark Beard - Executive Chairman Bret Christensen - C...